BioNTech SE Sponsored ADR (BNTX) shares rallied 11.8% in the last trading session to close at $118. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 12.1% gain over the past four weeks.The stock rallied after the company announced that the FDA has granted a Fast Track designation to its investigational mRNA cancer immunotherapy, BNT113 for the treatment of patients with human papillomavirus type 16 positive (“ ...